This study was aimed to determine the correlation of the risk of bone metastases in breast cancer based on the expressions of molecular markers: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2) and Ki-67. The gene discussed is ESR1; the disease is breast carcinoma.